Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Azuma

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 6, 2011
Three-dimensional microstructural changes in murine abdominal aortic aneurysms quantified using immunofluorescent array tomographySanaz Saatchi, Junya Azuma, Nishey Wanchoo, et al.
Atherosclerosis|December 17, 2011
Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic miceMasaaki Iwabayashi, Yoshiaki Taniyama, Fumihiro Sanada, et al.
Hypertension (Dallas, Tex. : 1979)|March 7, 2012
Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transitionKeita Okayama, Junya Azuma, Norio Dosaka, et al.
Circulation Research|August 29, 2009
Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cellsFumihiro Sanada, Yoshiaki Taniyama, Kazuma Iekushi, et al.
Hypertension (Dallas, Tex. : 1979)|July 9, 2004
Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial diseaseRyuichi Morishita, Motokuni Aoki, Naotaka Hashiya, et al.
Journal of Hypertension|September 16, 2010
Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblastsKazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemiaRyuichi Morishita, Hirofumi Makino, Motokuni Aoki, et al.
Current Gene Therapy|June 8, 2004
Therapeutic angiogenesis using hepatocyte growth factor (HGF)Ryuichi Morishita, Motokuni Aoki, Naotaka Hashiya, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2011
Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathwayKazuma Iekushi, Yoshiaki Taniyama, Hiroshi Kusunoki, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2012
Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockadeHiroshi Kusunoki, Yoshiaki Taniyama, Junya Azuma, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 6, 2011
Three-dimensional microstructural changes in murine abdominal aortic aneurysms quantified using immunofluorescent array tomographySanaz Saatchi, Junya Azuma, Nishey Wanchoo, et al.
Atherosclerosis|December 17, 2011
Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic miceMasaaki Iwabayashi, Yoshiaki Taniyama, Fumihiro Sanada, et al.
Hypertension (Dallas, Tex. : 1979)|March 7, 2012
Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transitionKeita Okayama, Junya Azuma, Norio Dosaka, et al.
Circulation Research|August 29, 2009
Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cellsFumihiro Sanada, Yoshiaki Taniyama, Kazuma Iekushi, et al.
Hypertension (Dallas, Tex. : 1979)|July 9, 2004
Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial diseaseRyuichi Morishita, Motokuni Aoki, Naotaka Hashiya, et al.
Journal of Hypertension|September 16, 2010
Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblastsKazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2010
Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemiaRyuichi Morishita, Hirofumi Makino, Motokuni Aoki, et al.
Current Gene Therapy|June 8, 2004
Therapeutic angiogenesis using hepatocyte growth factor (HGF)Ryuichi Morishita, Motokuni Aoki, Naotaka Hashiya, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2011
Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathwayKazuma Iekushi, Yoshiaki Taniyama, Hiroshi Kusunoki, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2012
Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockadeHiroshi Kusunoki, Yoshiaki Taniyama, Junya Azuma, et al.
Pageof 5